Literature DB >> 2889833

Testicular cancer risk in boys with maldescended testis: a cohort study.

A Giwercman1, J Grindsted, B Hansen, O M Jensen, N E Skakkebaek.   

Abstract

Testicular maldescent is considered as a predisposing condition for development of testicular malignancy. Male subjects with a history of cryptorchidism have been suggested by some authors to have a 40 to 50 times increased risk of testis cancer. However, the magnitude of this risk is a point of considerable disagreement. Therefore, we studied the records of 506 consecutive patients hospitalized for maldescended testis from January 1949 to December 1960. Testis cancer developed in 6 patients, which when compared to the 1.3 expectant Danish incidence rate, yielded a statistically significant relative risk of 4.7 (95 per cent confidence interval 1.7 to 10.2). Thus, our study confirmed that male subjects with a history of testicular maldescent have an increased risk for testis cancer, although the magnitude of this risk was lower than suggested previously.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2889833     DOI: 10.1016/s0022-5347(17)43553-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  31 in total

Review 1.  Clinical epidemiology of testicular germ cell tumors.

Authors:  K-P Dieckmann; U Pichlmeier
Journal:  World J Urol       Date:  2004-03-18       Impact factor: 4.226

Review 2.  A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer--experiences of the son.

Authors:  Michael B Cook; Olof Akre; David Forman; M Patricia Madigan; Lorenzo Richiardi; Katherine A McGlynn
Journal:  Int J Epidemiol       Date:  2010-07-26       Impact factor: 7.196

3.  Regional variations in testicular cancer rates in Ireland.

Authors:  M Alsinnawi; M R Quinlan; S Deady; E A Kiely
Journal:  Ir J Med Sci       Date:  2010-11-19       Impact factor: 1.568

Review 4.  Germ cell development in the descended and cryptorchid testis and the effects of hormonal manipulation.

Authors:  C Ong; S Hasthorpe; J M Hutson
Journal:  Pediatr Surg Int       Date:  2005-02-23       Impact factor: 1.827

Review 5.  The legacy of the F344 rat as a cancer bioassay model (a retrospective summary of three common F344 rat neoplasms).

Authors:  Robert R Maronpot; Abraham Nyska; Jennifer E Foreman; Yuval Ramot
Journal:  Crit Rev Toxicol       Date:  2016-06-09       Impact factor: 5.635

6.  Risk of testicular cancer with cryptorchidism and with testicular biopsy: cohort study.

Authors:  H Møller; D Cortes; G Engholm; J Thorup
Journal:  BMJ       Date:  1998-09-12

7.  Prevalence study of carcinoma in situ of testis in oligozoospermic men. Study was too small to show potential benefits of screening.

Authors:  R Rajentheran; J Kenworthy; M Cunnington
Journal:  BMJ       Date:  1998-05-02

8.  Risk of childhood mortality in family members of men with poor semen quality.

Authors:  Heidi A Hanson; Erik N Mayer; Ross E Anderson; Kenneth I Aston; Douglas T Carrell; Justin Berger; William T Lowrance; Ken R Smith; James M Hotaling
Journal:  Hum Reprod       Date:  2016-12-06       Impact factor: 6.918

9.  Delayed treatment of undescended testes may promote hypogonadism and infertility.

Authors:  Julia Rohayem; Alessandra Luberto; Eberhard Nieschlag; Michael Zitzmann; Sabine Kliesch
Journal:  Endocrine       Date:  2017-01-09       Impact factor: 3.633

10.  Risk of testicular cancer after vasectomy: cohort study of over 73,000 men.

Authors:  H Møller; L B Knudsen; E Lynge
Journal:  BMJ       Date:  1994-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.